DiaCarta Gets FDA Authorization for Monkeypox Test Kit
12 Janeiro 2023 - 11:22AM
Dow Jones News
By Dean Seal
DiaCarta Ltd. said U.S. regulators have granted Emergency Use
Authorization to its test kit for monkeypox infections.
The molecular diagnostics and disease-testing company said
Thursday morning that the U.S. Food and Drug Administration
extended the approval to its QuantiVirus MPXV test.
The test detects the monkeypox virus from lesion swabs and is
designed for laboratory use.
DiaCarta agreed in October to be acquired and taken public by
the blank-check company HH&L Acquisition Co. in a deal that
gave DiaCarta an implied pre-money equity value of $460 million.
The merger is expected to close this quarter.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
January 12, 2023 09:07 ET (14:07 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
HH&L Acquisition (NYSE:HHLA)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
HH&L Acquisition (NYSE:HHLA)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024